CA3093717A1 — Identification method for dermal sheath cup cells (dscc), and method for evaluating composition for hair follicle regeneration
Assigned to Shiseido Co Ltd · Expires 2019-09-19 · 7y expired
What this patent protects
Provided is an identification method for dermal sheath cup cells (DSCC) in hair follicle-derived cells, said method being characterized by comprising using the expression level of GREM2 gene as an index. Also provided is a method for evaluating a composition for hair follicle reg…
USPTO Abstract
Provided is an identification method for dermal sheath cup cells (DSCC) in hair follicle-derived cells, said method being characterized by comprising using the expression level of GREM2 gene as an index. Also provided is a method for evaluating a composition for hair follicle regeneration which contains hair follicle-derived cells, said method being characterized by comprising determining the ratio and/or activity of dermal sheath cup cells (DSCC) in the hair follicle-derived cells with the use of the expression level of GREM2 gene as an index.
Drugs covered by this patent
- Olumiant (baricitinib) · Eli Lilly
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.